7月にXのCEOを辞任したリンダ・ヤッカリーノ氏が、ヘルスケア企業eMedのCEOに就任した。eMedはデジタルヘルスプラットフォームを提供しており、同氏の経験が事業拡大に貢献すると期待されている。ヤッカリーノ氏にとって約1カ月での電撃復帰となる。

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...

Weight-loss focused digital company eMed Population Health on Tuesday named Linda Yaccarino, the former chief of Elon Musk's ...

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.

Former X CEO Linda Yaccarino has taken the helm at eMed Population Health, marking a bold shift from social media to digital healthcare leadership amid rising demand for weight-loss drugs and ...

通常のテストキットとは違う eMedの検査サービスはAbbottのBinaxNOWというテストキットとeMedが提供するビデオ通話による検査と陰性証明書発行の ...